Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 20, 2026 · Filed Oct 21, 2026
A major shareholder of Tenax Therapeutics paid $406K out of pocket for Tenax Therapeutics shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$405,726
Shares × reported transaction price
$100K–$500K
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 8 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
81 days after results of Jul 31, 2026, 16 days before results of Nov 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1.63 on Oct 20, 2026, 20% above its 52-week low and 91% below its high, after an 18% drop over the previous 30 trading days
52-week range $1.36 (Oct 16, 2026) to $18.32 (Jul 9, 2026), 2% of the way up, from 251 adjusted closes. 30 trading days earlier: $1.98 on Sep 8, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +5.7% | +0.7% | +5.0% |
Past results only. Not a forecast.
Fund moves
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Insider buying
Traded Oct 21 · filed the same day
A major shareholder of Tenax Therapeutics paid $551K out of pocket for Tenax Therapeutics shares.
Insider buying
Traded Oct 19 · filed 2 days later
A major shareholder of Tenax Therapeutics paid $507K out of pocket for Tenax Therapeutics shares.
ADAR1 Capital Management, LLC, 10% owner's past purchases, 90 days after disclosure: 9 buys, median +2.3 pts vs S&P 500, beat it 6 of 9 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
